The Delhi High Court has rejected a petition seeking to halt India's HPV vaccination program, allowing the immunization initiative to proceed while requesting detailed safety documentation from the central government. The court acknowledged concerns raised through public interest litigation regarding vaccine safety protocols and efficacy data, demonstrating judicial oversight of public health initiatives. This decision balances public health priorities with transparency requirements, ensuring both program continuation and comprehensive government accountability.

Summary auto-generated by AI from the original publisher's content. Editorial standards.